All Posts

AACPN welcomes the U.S. Department of Veterans Affairs’ launch of a clinical trial evaluating MDMA-assisted therapy for veterans living with PTSD and alcohol use disorder. The organization says rigorous scientific research is essential to understanding whether emerging therapies can safely and effectively support veterans and other trauma survivors facing complex behavioral health challenges.

The American Alternative Care Policy Network has launched a new initiative opposing upcoming federal restrictions on hemp-derived THC beverages and advocating for responsible, science-based regulation focused on consumer safety, harm reduction, trauma recovery, and evidence-based alternative care policy.

The U.S. Department of Veterans Affairs has launched a new MDMA-assisted therapy clinical trial focused on veterans with PTSD and trauma-related conditions. The initiative reflects growing interest in evidence-based psychedelic-assisted therapies and broader efforts to expand innovative mental health treatment options for veterans and other trauma survivors.

The TSA’s updated guidance on medical marijuana travel marks a significant step toward more practical and patient-centered federal cannabis policy. AACPN examines what the change means for veterans, medical cannabis patients, and the future of domestic travel reform.

Read the full article

The American Alternative Care Policy Network (AACPN) welcomes the unanimous passage of Louisiana legislation establishing a state-backed psychedelic-assisted therapy research initiative focused on mental health and substance-use disorders. The legislation reflects growing bipartisan recognition that treatment-resistant mental illness, PTSD, addiction, and veteran suicide require continued exploration of evidence-informed therapeutic innovation and expanded clinical research.

The proposal would create a state initiative for clinical studies involving ibogaine and psilocybin

The American Alternative Care Policy Network (AACPN) today announced its launch, establishing a policy-driven platform to accelerate the integration of evidence-based alternative therapies into the U.S. healthcare system—where they can deliver measurable outcomes, expand access, and reduce long-term costs. AACPN enters a fragmented and often unserious policy environment with a clear mandate: impose rigor, elevate standards, and translate validated therapies into actionable le

Read the full order here

The American Alternative Care Policy Network (AACPN) today issued the following statement in response to the Department of Justice’s decision to reclassify marijuana as a Schedule III substance under the Controlled Substances Act: “The Department of Justice’s decision to reschedule marijuana from Schedule I to Schedule III marks a meaningful, if overdue, shift in federal policy. By recognizing accepted medical use, this action begins to correct a long-standing misalignment be

Press release: Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls

The American Alternative Care Policy Network (AACPN) today issued the following statement in response to the White House executive order, “Breakthrough Mental Health Treatments — Delivering New Hope to Veterans,” which accelerates research and access to emerging therapies for serious mental illness: “The administration’s executive order represents a consequential shift in federal mental health policy—one that recognizes a hard truth: for millions of Americans suffering from..

Press release: President Trump’s Landmark Order Advances Breakthrough Mental Health Treatments — Delivering New Hope to Veterans

A White House executive order on psychedelics, signed by President Donald Trump on Saturday, aims to speed up research on drugs like psilocybin, MDMA and ibogaine, helping to legitimize an industry that’s long lived largely underground.

Executive Order: Accelerating Medical Treatments for Serious Mental Illness Fact Sheet: President Donald J. Trump is Accelerating Medical Treatments for Serious Mental Illness